These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 8358239
1. Manifesting carriers of Xp21 muscular dystrophy; lack of correlation between dystrophin expression and clinical weakness. Sewry CA, Sansome A, Clerk A, Sherratt TG, Hasson N, Rodillo E, Heckmatt JZ, Strong PN, Dubowitz V. Neuromuscul Disord; 1993 Mar; 3(2):141-8. PubMed ID: 8358239 [Abstract] [Full Text] [Related]
2. Expression of dystrophin-associated glycoproteins and utrophin in carriers of Duchenne muscular dystrophy. Sewry CA, Matsumura K, Campbell KP, Dubowitz V. Neuromuscul Disord; 1994 Mar; 4(5-6):401-9. PubMed ID: 7881285 [Abstract] [Full Text] [Related]
3. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Nicholson LV, Johnson MA, Gardner-Medwin D, Bhattacharya S, Harris JB. Acta Neuropathol; 1990 Mar; 80(3):239-50. PubMed ID: 2205076 [Abstract] [Full Text] [Related]
4. Characterisation of dystrophin in carriers of Duchenne muscular dystrophy. Clerk A, Rodillo E, Heckmatt JZ, Dubowitz V, Strong PN, Sewry CA. J Neurol Sci; 1991 Apr; 102(2):197-205. PubMed ID: 2072119 [Abstract] [Full Text] [Related]
6. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis. Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E. J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069 [Abstract] [Full Text] [Related]
7. Sarcolemmal distribution of abnormal dystrophin in Xp21 carriers. Vainzof M, Nicholson LV, Bulman DE, Tsanaclis AM, Passos-Bueno MR, Pavanello RC, Zatz M. Neuromuscul Disord; 1993 Mar; 3(2):135-40. PubMed ID: 7689380 [Abstract] [Full Text] [Related]
8. X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers. Wenger SL, Steele MW, Hoffman EP, Barmada MA, Wessel HB. Am J Med Genet; 1992 Aug 01; 43(6):1012-5. PubMed ID: 1415326 [Abstract] [Full Text] [Related]
9. Quantitative and qualitative alterations of dystrophin are expressed in muscle cell cultures of Xp21 muscular dystrophy patients (Duchenne and Becker type). Mongini T, Doriguzzi C, Palmucci L, Chiadò-Piat L. Eur J Clin Invest; 1996 Apr 01; 26(4):322-4. PubMed ID: 8732491 [Abstract] [Full Text] [Related]
10. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Hoffman EP, Kunkel LM, Angelini C, Clarke A, Johnson M, Harris JB. Neurology; 1989 Aug 01; 39(8):1011-7. PubMed ID: 2668783 [Abstract] [Full Text] [Related]
11. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy. Bushby KM, Goodship JA, Nicholson LV, Johnson MA, Haggerty ID, Gardner-Medwin D. Neuromuscul Disord; 1993 Jan 01; 3(1):57-64. PubMed ID: 8329890 [Abstract] [Full Text] [Related]